Clinical Trials Browser

Phase 3 × Prostatic Neoplasms, Castration-Resistant × enzalutamide × Clear all

NCT03016312 2024-08-09

IMbassador250

Phase 3 Completed

759 enrolled 22 charts

Prostatic Neoplasms, Castration-Resistant

NCT04844749 2024-02-05

VERACITY

Phase 3 Terminated

Prostatic Neoplasms, Castration-Resistant